Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AN2728 in Plaque Psoriasis
NCT01029405Phase 2Completed
- Sponsor
- Pfizer
- Start
- Nov 2009
- Primary completion
- May 2010
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of AN2728 ointment vehicle in plaque psoriasis (5 arms), sponsored by Pfizer. Primary endpoint: Percentage of Participants With Greater Decrease In Overall Target Plaque Severity Score (OTPSS) at Day 42. Started Nov 2009; status: completed.
02
Drugs
AN2728 ointment vehicle
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT01029405.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01029405.